Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

Keyphrases

• High Risk 100%
• Mortality Risk 100%
• Community-acquired Pneumonia 100%
• Immunological Characteristics 100%
• Lymphocytes 60%
• Lymphocyte Count 60%
• Validation Cohort 40%
• CURB-65 Score 40%
• Neutrophil Count 40%
• Multivariate Analysis 20%
• Hospitalized Patients 20%
• Critical Illness 20%
• Hospital Admission 20%
• Antibiotic Treatment 20%
• Clinical Management 20%
• Appropriate Antibiotics 20%
• Immunosuppression 20%
• Post-hospital 20%
• Prognosis Prediction 20%
• Non-survivors 20%

Medicine and Dentistry

• Community-Acquired Pneumonia 100%
• Lymphocyte 100%
• Neutrophil 33%
• Disease 16%
• Multivariate Analysis 16%
• Retrospective Study 16%
• Antibiotic Therapy 16%
• Clinical Management 16%
• Critical Illness 16%
• Immunosuppressive Treatment 16%

Immunology and Microbiology

• Lymphocyte Count 100%
• Lymphocyte 100%
• Neutrophil Count 66%
• Immunosuppression 33%